Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

294 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of Astatine-211-Labeled Fibroblast Activation Protein Inhibitor (FAPI): Comparison of Different Linkers with Polyethylene Glycol and Piperazine.
Aso A, Nabetani H, Matsuura Y, Kadonaga Y, Shirakami Y, Watabe T, Yoshiya T, Mochizuki M, Ooe K, Kawakami A, Jinno N, Toyoshima A, Haba H, Wang Y, Cardinale J, Giesel FL, Shimoyama A, Kaneda-Nakashima K, Fukase K. Aso A, et al. Among authors: fukase k. Int J Mol Sci. 2023 May 12;24(10):8701. doi: 10.3390/ijms24108701. Int J Mol Sci. 2023. PMID: 37240044 Free PMC article.
Comparison of Nuclear Medicine Therapeutics Targeting PSMA among Alpha-Emitting Nuclides.
Kaneda-Nakashima K, Shirakami Y, Kadonaga Y, Watabe T, Ooe K, Yin X, Haba H, Shirasaki K, Kikunaga H, Tsukada K, Toyoshima A, Cardinale J, Giesel FL, Fukase K. Kaneda-Nakashima K, et al. Among authors: fukase k. Int J Mol Sci. 2024 Jan 11;25(2):933. doi: 10.3390/ijms25020933. Int J Mol Sci. 2024. PMID: 38256007 Free PMC article.
Preclinical Evaluation of Biodistribution and Toxicity of [211At]PSMA-5 in Mice and Primates for the Targeted Alpha Therapy against Prostate Cancer.
Watabe T, Kaneda-Nakashima K, Kadonaga Y, Ooe K, Sampunta T, Hirose N, Yin X, Haba H, Kon Y, Toyoshima A, Cardinale J, Giesel FL, Fukase K, Tomiyama N, Shirakami Y. Watabe T, et al. Among authors: fukase k. Int J Mol Sci. 2024 May 23;25(11):5667. doi: 10.3390/ijms25115667. Int J Mol Sci. 2024. PMID: 38891856 Free PMC article.
Development of LAT1-Selective Nuclear Medicine Therapeutics Using Astatine-211.
Kaneda-Nakashima K, Shirakami Y, Hisada K, Feng S, Kadonaga Y, Ooe K, Watabe T, Manabe Y, Shimoyama A, Murakami M, Toyoshima A, Haba H, Kanai Y, Fukase K. Kaneda-Nakashima K, et al. Among authors: fukase k. Int J Mol Sci. 2024 Nov 18;25(22):12386. doi: 10.3390/ijms252212386. Int J Mol Sci. 2024. PMID: 39596451 Free PMC article.
α-Emitting cancer therapy using 211 At-AAMT targeting LAT1.
Kaneda-Nakashima K, Zhang Z, Manabe Y, Shimoyama A, Kabayama K, Watabe T, Kanai Y, Ooe K, Toyoshima A, Shirakami Y, Yoshimura T, Fukuda M, Hatazawa J, Nakano T, Fukase K, Shinohara A. Kaneda-Nakashima K, et al. Among authors: fukase k. Cancer Sci. 2021 Mar;112(3):1132-1140. doi: 10.1111/cas.14761. Epub 2021 Jan 22. Cancer Sci. 2021. PMID: 33277750 Free PMC article.
294 results